Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024
Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024
Presentation ACC 2024 Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial Presenter: Gregg W Stone April 07, 2024
Presentation ACC 2024 Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock Presenter: Jacob Eifer Møller April 07, 2024
Presentation ACC 2024 Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial Presenter: Javed Butler April 06, 2024
Presentation ACC 2023 Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease Presenter: Roberto Diletti March 05, 2023
Presentation ACC 2022 The Clinical Effect Of Arrhythmia Monitoring After Myocardial Infarction Presenter: Christian Jons April 04, 2022
Presentation ACC 2021 Randomized trial of high sensitivity Troponin T in the Emergency Department Presenter: Derek Chew May 18, 2021
Presentation ACC 2020 Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial Presenter: Yangsoo Jang March 30, 2020
Presentation ACC 2020 Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI Presenter: Zakaria Almuwaqqat March 30, 2020
Presentation ACC 2019 The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial Presenter: Michel R Le May March 19, 2019
Presentation ACC 2019 Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial Presenter: Renato Lopes March 18, 2019
Presentation ACC 2019 Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial Presenter: Adam D. DeVore March 17, 2019
Presentation ACC 2018 6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE) Presenter: Hyeon-Cheol Gwon March 12, 2018
Presentation ACC 2018 A Pragmatic Randomized Trial of CYP2C19 Genotyping Implementation Following Percutaneous Coronary Intervention (PCI) Presenter: Sony Tuteja March 12, 2018
Presentation ACC 2018 ARTEMIS: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Presenter: Tracy Wang March 12, 2018
Presentation ACC 2018 Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study Presenter: Ajay J. Kirtane March 11, 2018
Presentation ACC 2018 Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery Presenter: Nathaniel R. Smilowitz March 11, 2018
Presentation ACC 2017 A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Presenter: Magnus Ohman March 27, 2017
Presentation ACC 2017 iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017